mepivacaine has been researched along with Facial Neoplasms in 1 studies
Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
Facial Neoplasms: New abnormal growth of tissue in the FACE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passavanti, MB | 1 |
| Grella, E | 1 |
| Pace, MC | 1 |
| Di Gennaro, TL | 1 |
| Aurilio, C | 1 |
1 trial available for mepivacaine and Facial Neoplasms
| Article | Year |
|---|---|
Tramadol as a local anesthetic: prospects for use in oncological day surgery.
Topics: Adult; Ambulatory Surgical Procedures; Analgesics, Opioid; Anesthetics, Local; Carcinoma, Basal Cell | 2013 |